These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11160176)

  • 41. Quality assurance and ergonomics in the mammography department.
    Reynolds A
    Radiol Technol; 2014; 86(1):61M-79M; quiz 80M-83M. PubMed ID: 25224096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Quality assured images in mammographic screening. Assessment criteria as a basis for national guidelines].
    Ståhl M; Edström C
    Lakartidningen; 2001 Mar; 98(10):1097-101. PubMed ID: 11301976
    [No Abstract]   [Full Text] [Related]  

  • 43. Value of audits in breast cancer screening quality assurance programmes.
    Geertse TD; Holland R; Timmers JM; Paap E; Pijnappel RM; Broeders MJ; den Heeten GJ
    Eur Radiol; 2015 Nov; 25(11):3338-47. PubMed ID: 25903711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality assurance. How to audit your own mammography practice.
    Sickles EA
    Radiol Clin North Am; 1992 Jan; 30(1):265-75. PubMed ID: 1732933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project).
    Katalinic A; Bartel C; Raspe H; Schreer I
    Br J Cancer; 2007 Jan; 96(1):157-61. PubMed ID: 17179994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Film-screen combinations for mammography].
    Säbel M; Aichinger H
    Aktuelle Radiol; 1991 May; 1(3):105-12. PubMed ID: 1878377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Concept and implementation of model projects for mammography screening in Germany].
    Junkermann H; Becker N; Peitgen HO
    Radiologe; 2001 Apr; 41(4):328-36. PubMed ID: 11388053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Typetesting of physical characteristics of digital mammography systems: first experiences within the Flemish breast cancer screening programme.
    Thierens H; Bosmans H; Buls N; Bacher K; De Hauwere A; Jacobs J; Clerinx P
    JBR-BTR; 2007; 90(3):159-62. PubMed ID: 17696080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follow-up of abnormal results in an urban community-based breast cancer screening program.
    Fillmore CM; Beekman SR; Farmer BJ; Gold ML
    WMJ; 2003; 102(5):46-7. PubMed ID: 14621931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A quality assurance programme for mass screening in mammography.
    Australas Phys Eng Sci Med; 1989 Dec; 12(4):252-9. PubMed ID: 2610641
    [No Abstract]   [Full Text] [Related]  

  • 51. Implementing digital quality control in a breast center.
    Parikh J; Fanus D
    J Am Coll Radiol; 2004 Nov; 1(11):854-60. PubMed ID: 17411717
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [European recommendations for quality assurance in the setting of mammographic screening for breast cancer. Report of pathologists of the working group "Breast Cancer Screening" of the European Union].
    Ann Pathol; 1996 Nov; 16(5):315-33. PubMed ID: 9004719
    [No Abstract]   [Full Text] [Related]  

  • 53. Methodological issues in international comparison of interval breast cancers.
    Bulliard JL; Sasieni P; Klabunde C; De Landtsheer JP; Yankaskas BC; Fracheboud J
    Int J Cancer; 2006 Sep; 119(5):1158-63. PubMed ID: 16570280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast cancer: when and how often to get screened. How do you make sense of conflicting mammography guidelines?
    Harv Womens Health Watch; 2013 Oct; 21(2):3. PubMed ID: 24432454
    [No Abstract]   [Full Text] [Related]  

  • 55. A comparison of the performance and impact of breast cancer screening programmes in East Anglia, U.K. and Bouches du Rhône, France.
    McCann J; Wait S; Séradour B; Day N
    Eur J Cancer; 1997 Mar; 33(3):429-35. PubMed ID: 9155528
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improvement of early detection of breast cancer through collaborative multi-country efforts: Observational clinical study.
    Aribal E; Mora P; Chaturvedi AK; Hertl K; Davidović J; Salama DH; Gershan V; Kadivec M; Odio C; Popli M; Kisembo H; Sabih Z; Vujnović S; Kayhan A; Delis H; Paez D; Giammarile F
    Eur J Radiol; 2019 Jun; 115():31-38. PubMed ID: 31084756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How do the latest breast cancer screening recommendations affect you?
    Health After 50 Sci Am Consum Health; 2016 Feb; 27(15):4-5. PubMed ID: 27062757
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effectiveness of population-based breast cancer screening programme].
    Szynglarewicz B; Matkowski R; Kasprzak P; Kotowska J; Forgacz J; Pudełko M; Kornafel J
    Pol Merkur Lekarski; 2009 Feb; 26(152):117-20. PubMed ID: 19388515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The quality of mammography scrutinized. Ongoing control mass screenings for breast cancer is necessary].
    Andersson I; Rydén S; Karlberg I
    Lakartidningen; 1995 Aug; 92(35):3106-9. PubMed ID: 7658762
    [No Abstract]   [Full Text] [Related]  

  • 60. A survey by the European Society of Breast Imaging on radiologists' preferences regarding quality assurance measures of image interpretation in screening and diagnostic mammography.
    Michalopoulou E; Clauser P; Gilbert FJ; Pijnappel RM; Mann RM; Baltzer PAT; Chen Y; Fallenberg EM
    Eur Radiol; 2023 Nov; 33(11):8103-8111. PubMed ID: 37481690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.